These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3292146)

  • 1. Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function.
    Grützmacher P; Scheuermann E; Löw I; Bergmann M; Rauber K; Baum R; Heuser J; Schoeppe W
    Contrib Nephrol; 1988; 66():176-84. PubMed ID: 3292146
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
    Grützmacher P; Bergmann M; Weinreich T; Nattermann U; Reimers E; Pollok M
    Contrib Nephrol; 1988; 66():104-13. PubMed ID: 3292143
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R; Hand M
    N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of renal anaemia by recombinant human erythropoietin.
    Stifter S; Graf H
    Pol Arch Med Wewn; 1991 Jun; 85(6):329-33. PubMed ID: 1896395
    [No Abstract]   [Full Text] [Related]  

  • 6. Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin.
    Zehnter E; Pollok M; Ziegenhagen D; Bramsiepe P; Longere F; Baldamus CA; Wellner U; Waters W
    Contrib Nephrol; 1988; 66():149-55. PubMed ID: 3391029
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
    Bommer J; Huber W; Tewes G; Ritz E; von Wedel S; Küppers S; Weinreich T; Bommer G
    Contrib Nephrol; 1988; 66():131-8. PubMed ID: 3391027
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiologic respiratory parameters in erythropoietin treatment of patients with chronic renal failure].
    Stummvoll HK; Schindl R; Aigner K; Würtz J; Breitenfellner P; Graf H
    Wien Med Wochenschr Suppl; 1989; 104():suppl 50-2. PubMed ID: 2588636
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin: implications for nephrology.
    Eschbach JW; Adamson JW
    Am J Kidney Dis; 1988 Mar; 11(3):203-9. PubMed ID: 3278599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin.
    Pfåffl W; Gross HJ; Neumeier D; Nattermann U; Samtleben W; Gurland HJ
    Contrib Nephrol; 1988; 66():195-204. PubMed ID: 3391032
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin: the significance in therapeutic system of renal failure; clinical efficacy of erythropoietin].
    Nihon Jinzo Gakkai Shi; 1989 May; 31(5):435-9. PubMed ID: 2622074
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure changes during treatment with recombinant human erythropoietin.
    Samtleben W; Baldamus CA; Bommer J; Fassbinder W; Nonnast-Daniel B; Gurland HJ
    Contrib Nephrol; 1988; 66():114-22. PubMed ID: 3292144
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
    Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
    Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.